JPMorgan raised the firm’s price target on Syndax (SNDX) to $38 from $33 and keeps an Overweight rating on the shares. The firm updated models in the smid-cap biotechnology space.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNDX: